{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:58:05Z","timestamp":1785437885793,"version":"3.56.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Weight reduction is a well-established disease-modifying intervention in the management of idiopathic intracranial hypertension (IIH), with clinical guidelines commonly recommending a target of at least 10% total body weight loss to achieve meaningful symptom improvement and reduction in intracranial pressure (ICP). Multiple modalities can be employed to facilitate weight loss, including lifestyle modification, pharmacologic therapy, and bariatric surgery. Among pharmacologic interventions, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have demonstrated superior efficacy in achieving significant weight loss compared to conventional weight management strategies. Recent reports from ongoing studies have also indicated that GLP-1 RAs may reduce the need for acetazolamide, a standard treatment used to decrease cerebrospinal fluid (CSF) production in IIH, as they not only reduce ICP through weight loss but also have direct effects on CSF production. This review evaluates the role of GLP-1 RAs in IIH, highlighting their mechanisms, benefits, and emerging research. Challenges include limited IIH-specific data, high costs, side effects, and the need for long-term therapy. While early findings are promising, larger trials are needed. GLP-1 RAs should complement, not replace, comprehensive lifestyle and multidisciplinary IIH management strategies.<\/jats:p>","DOI":"10.4103\/ijo.ijo_1125_25","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:00:18Z","timestamp":1785434418000},"page":"1122-1128","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The emerging role of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: Therapeutic potential and challenges"],"prefix":"10.4103","volume":"74","author":[{"given":"Mangayakarasi","family":"Thandampallayam","sequence":"first","affiliation":[{"name":"Department of Neurology and Ophthalmology, University of Kentucky, Lexington, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khawla","family":"Abusamra","sequence":"additional","affiliation":[{"name":"Department of Neurology, Newton Medical Center, Newton, KS, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Kini","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centennial Neurosciences, Tristar Centennial, Belmont University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani P","family":"Vasireddy","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Kentucky, Lexington, Kentucky, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"R1-20260730","first-page":"1821","article-title":"The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: A randomized clinical trial","volume":"146","author":"Mitchell","year":"2023","journal-title":"Brain"},{"key":"R2-20260730","first-page":"201","article-title":"Exploring the pathogenesis of IIH: An inflammatory perspective","author":"Sinclair","year":"2008","journal-title":"J Neuroimmunol"},{"key":"R3-20260730","first-page":"492","article-title":"Intracranial pressure without brain tumor: Diagnosis and treatment","volume":"106","author":"Dandy","year":"1937","journal-title":"Ann Surg"},{"key":"R4-20260730","first-page":"104","article-title":"Cerebral hemodynamics and metabolism in pseudotumor cerebri","volume":"4","author":"Raichle","year":"1978","journal-title":"Ann Neurol"},{"key":"R5-20260730","first-page":"1564","article-title":"Weight gain and recurrence in idiopathic intracranial hypertension: A case-control study","volume":"76","author":"Ko","year":"2011","journal-title":"Neurology"},{"key":"R6-20260730","first-page":"304","article-title":"Idiopathic intracranial hypertension in men","volume":"72","author":"Bruce","year":"2009","journal-title":"Neurology"},{"key":"R7-20260730","first-page":"4812","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: A new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J Neurosci"},{"key":"R8-20260730","first-page":"292","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: A systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"R9-20260730","first-page":"258","article-title":"Efficacy and safety of once-weekly semaglutide versus exenatide er in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial","volume":"41","author":"Ahmann","year":"2018","journal-title":"Diabetes Care"},{"key":"R10-20260730","first-page":"86","article-title":"Activation of microglial GLP-1R in the trigeminal nucleus caudalis suppresses central sensitization of chronic migraine after recurrent nitroglycerin stimulation","volume":"22","author":"Jing","year":"2021","journal-title":"J Headache Pain"},{"key":"R11-20260730","first-page":"46","article-title":"Advances in GLP-1 receptor agonists for pain treatment and their future potential","volume":"26","author":"He","year":"2025","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"R12-20260730","first-page":"17","article-title":"A review of GLP-1 receptor agonists in type 2 diabetes: A focus on the mechanism of action of once-weekly agents","volume":"45 Suppl 1","author":"Cornell","year":"2020","journal-title":"J Clin Pharm Ther"},{"key":"R13-20260730","first-page":"202","article-title":"Adverse Effects of GLP-1 Receptor Agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud"},{"key":"R14-20260730","first-page":"e104873","article-title":"Divergent effects of liraglutide, exendin-4, and sitagliptin on beta-cell mass and indicators of pancreatitis in a mouse model of hyperglycaemia","volume":"9","author":"Mondragon","year":"2014","journal-title":"PLoS One"},{"key":"R15-20260730","first-page":"1482","article-title":"Hypoglycemia following the use of glucagon-like peptide-1 receptor agonists: A real-world analysis of post-marketing surveillance data","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann Transl Med"},{"key":"R16-20260730","first-page":"1032199","article-title":"Can glucagon-like peptide-1 receptor agonists cause acute kidney injury? An analytical study based on post-marketing approval pharmacovigilance data","volume":"13","author":"Dong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R17-20260730","first-page":"732","article-title":"Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide","volume":"142","author":"Hathaway","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"R18-20260730","first-page":"1538","article-title":"GLP-1 receptor agonists and the thyroid: C-cell effects in mice are mediated via the GLP-1 receptor and not associated with RET activation","volume":"153","author":"Madsen","year":"2012","journal-title":"Endocrinology"},{"key":"R19-20260730","first-page":"eaan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci Transl Med"},{"key":"R20-20260730","first-page":"2090","article-title":"The effect of glucagon-like peptide-1 agonists on ocular parameters in idiopathic intracranial hypertension patients: A retrospective study","volume":"39","author":"Kravetz","year":"2025","journal-title":"Eye (Lond)"},{"key":"R21-20260730","first-page":"89","article-title":"Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension","volume":"24","author":"Krajnc","year":"2023","journal-title":"J Headache Pain"},{"key":"R22-20260730","article-title":"Efficacy of Tirzepatide Dual GIP\/GLP-1 Receptor Agonist In Patients with Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study","author":"Azzam","year":"2024","journal-title":"medRxiv [Preprint]"},{"issue":"2","key":"R22-20260730","first-page":"e70019","article-title":"Update","volume":"8","year":"2025","journal-title":"Endocrinol Diabetes Metab"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1125_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T18:00:39Z","timestamp":1785434439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_1125_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1125_25","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"assertion":[{"value":"2025-05-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}